Intevac Announces Third Quarter 2016 Financial Results
Tue, November 1 2016
“We are pleased to announce financial results for the third quarter that
exceeded our expectations,” commented
($ Millions, except per share amounts) |
Q3 2016 | Q3 2015 | ||||||||||||||
GAAP Results | Non-GAAP Results | GAAP Results | Non-GAAP Results | |||||||||||||
Net Revenues | $ | 22.6 | $ | 22.6 | $ | 18.4 | $ | 18.4 | ||||||||
Operating Loss | $ | (0.3 | ) | $ | (0.3 | ) | $ | (3.8 | ) | $ | (3.9 | ) | ||||
Net Loss | $ | (0.5 | ) | $ | (0.4 | ) | $ | (3.8 | ) | $ | (3.9 | ) | ||||
Net Loss per Share | $ | (0.02 | ) | $ | (0.02 | ) | $ | (0.17 | ) | $ | (0.18 | ) | ||||
|
Nine Months Ended |
Nine Months Ended |
||||||||||||||
GAAP Results | Non-GAAP Results | GAAP Results | Non-GAAP Results | |||||||||||||
Net Revenues | $ | 51.1 | $ | 51.1 | $ | 58.8 | $ | 58.8 | ||||||||
Operating Loss | $ | (10.4 | ) | $ | (10.5 | ) | $ | (6.4 | ) | $ | (6.6 | ) | ||||
Net Loss | $ | (10.3 | ) | $ | (10.4 | ) | $ | (6.6 | ) | $ | (6.8 | ) | ||||
Net Loss per Share | $ | (0.50 | ) | $ | (0.50 | ) | $ | (0.29 | ) | $ | (0.30 | ) |
Intevac’s non-GAAP adjusted results exclude the impact of the following, where applicable: (1) changes in fair value of contingent consideration liabilities associated with business combinations; and (2) restructuring charges. A reconciliation of the GAAP and non-GAAP adjusted results is provided in the financial table included in this release. See also “Use of Non-GAAP Financial Measures” section.
Third Quarter 2016 Summary
The net loss for the quarter was
Revenues were
Thin-film Equipment gross margin was 32.4% compared to 17.8% in the third quarter of 2015 and 36.2% in the second quarter of 2016. The improvement from the third quarter of 2015 reflected a higher level of revenue and improved factory absorption. The decline from the second quarter of 2016 reflected a higher mix of systems shipments versus higher-margin upgrades and higher inventory provisions, offset in part by improved factory absorption.
Photonics gross margin was 46.9% compared to 35.5% in the third quarter of 2015 and 44.4% in the second quarter of 2016. The improvement from the third quarter of 2015 and the second quarter of 2016 was due to improved sensor yields and higher margins on research and development contracts. Consolidated gross margin was 37.7%, compared to 26.7% in the third quarter of 2015 and 41.1% in the second quarter of 2016.
R&
Order backlog totaled
The Company ended the quarter with
First Nine Months 2016 Summary
The net loss was
Revenues were
Thin-film Equipment gross margin was 28.3%, compared to 30.0% in the first nine months of 2015. The decline reflected a higher mix of systems shipments versus higher-margin upgrades and higher inventory provisions. Photonics gross margin was 44.3% compared to 37.4% in the first nine months of 2015, reflecting improved sensor yields and lower inventory provisions. Consolidated gross margin was 36.2%, compared to 33.4% in the first nine months of 2015.
R&
Use of Non-GAAP Financial Measures
Management uses non-GAAP results to evaluate the Company’s operating and
financial performance in light of business objectives and for planning
purposes. These measures are not in accordance with GAAP and may differ
from non-GAAP methods of accounting and reporting used by other
companies.
Conference Call Information
The Company will discuss its financial results and outlook in a
conference call today at 1:30 p.m. PDT (4:30 p.m. EDT). To participate
in the teleconference, please call toll-free (877) 334-0811 prior to the
start time. For international callers, the dial-in number is
(408) 427-3734. You may also listen live via the
About
In our Thin-film Equipment business, we are a leader in the design and development of high-productivity, thin-film processing systems. Our production-proven platforms are designed for high-volume manufacturing of substrates with precise thin film properties, such as the hard drive media, display cover panel, and solar photovoltaic markets we serve currently.
In our Photonics business, we are a recognized leading developer of
advanced high-sensitivity digital sensors, cameras and systems that
primarily serve the defense industry. We are the provider of integrated
digital imaging systems for most
For more information call 408-986-9888, or visit the Company's website at www.intevac.com.
200 Lean® is a registered trademark and
Safe Harbor Statement
This press release includes statements that constitute “forward-looking
statements” within the meaning of the Private Securities Litigation
Reform Act of 1995 (the “Reform Act”).
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited, in thousands, except per share amounts) |
||||||||||||||||
Three months ended | Nine months ended | |||||||||||||||
|
|
|
|
|||||||||||||
Net revenues | ||||||||||||||||
Thin-film Equipment | $ | 14,272 | $ | 9,192 | $ | 25,941 | $ | 31,314 | ||||||||
Photonics | 8,287 | 9,226 | 25,201 | 27,448 | ||||||||||||
Total net revenues | 22,559 | 18,418 | 51,142 | 58,762 | ||||||||||||
Gross profit | 8,515 | 4,912 | 18,497 | 19,640 | ||||||||||||
Gross margin | ||||||||||||||||
Thin-film Equipment | 32.4 | % | 17.8 | % | 28.3 | % | 30.0 | % | ||||||||
Photonics | 46.9 | % | 35.5 | % | 44.3 | % | 37.4 | % | ||||||||
Consolidated | 37.7 | % | 26.7 | % | 36.2 | % | 33.4 | % | ||||||||
Operating expenses | ||||||||||||||||
Research and development | 4,067 | 3,956 | 14,220 | 11,511 | ||||||||||||
Selling, general and administrative | 4,720 | 4,886 | 14,814 | 14,915 | ||||||||||||
Acquisition-related1 | 52 | (150 | ) | (90 | ) | (350 | ) | |||||||||
Total operating expenses | 8,839 | 8,692 | 28,944 | 26,076 | ||||||||||||
Total operating loss | (324 | ) | (3,780 | ) | (10,447 | ) | (6,436 | ) | ||||||||
Operating income (loss) | ||||||||||||||||
Thin-film Equipment | (998 | ) | (3,935 | ) | (10,117 | ) | (7,226 | ) | ||||||||
Photonics | 1,737 | 1,308 | 3,656 | 4,060 | ||||||||||||
Corporate | (1,063 | ) | (1,153 | ) | (3,986 | ) | (3,270 | ) | ||||||||
Total operating loss | (324 | ) | (3,780 | ) | (10,447 | ) | (6,436 | ) | ||||||||
Interest income and other income (expense), net | 60 | 23 | 184 | 88 | ||||||||||||
Loss before income taxes | (264 | ) | (3,757 | ) | (10,263 | ) | (6,348 | ) | ||||||||
Provision for income taxes | 217 | 2 | 13 | 292 | ||||||||||||
Net loss | $ | (481 | ) | $ | (3,759 | ) | $ | (10,276 | ) | $ | (6,640 | ) | ||||
Net Loss per share | ||||||||||||||||
Basic and Diluted | $ | (0.02 | ) | $ | (0.17 | ) | $ | (0.50 | ) | $ | (0.29 | ) | ||||
Weighted average common shares outstanding | ||||||||||||||||
Basic and Diluted | 20,869 | 22,004 | 20,704 | 22,621 |
1Results for all periods presented include changes in fair value of contingent consideration obligations associated with the Solar Implant Technology (SIT) acquisition in 2010.
CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands, except par value) |
||||||||
|
|
|||||||
(Unaudited) | (see Note) | |||||||
ASSETS | ||||||||
Current assets | ||||||||
Cash, cash equivalents and short-term investments | $ | 36,645 | $ | 36,954 | ||||
Accounts receivable, net | 19,014 | 12,310 | ||||||
Inventories | 26,914 | 18,760 | ||||||
Prepaid expenses and other current assets | 1,968 | 1,712 | ||||||
Total current assets | 84,541 | 69,736 | ||||||
Long-term investments | 4,257 | 9,673 | ||||||
Restricted cash | 1,958 | 1,780 | ||||||
Property, plant and equipment, net | 11,348 | 11,921 | ||||||
Intangible assets, net | 2,472 | 3,112 | ||||||
Other long-term assets | 952 | 1,459 | ||||||
Total assets | $ | 105,528 | $ | 97,681 | ||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
Current liabilities | ||||||||
Accounts payable | $ | 5,814 | $ | 5,950 | ||||
Accrued payroll and related liabilities |
3,750 |
4,066 |
||||||
Other accrued liabilities | 8,536 | 5,632 | ||||||
Customer advances | 14,247 | 3,625 | ||||||
Total current liabilities | 32,347 | 19,273 | ||||||
Other long-term liabilities | 3,319 | 2,411 | ||||||
Stockholders’ equity | ||||||||
Common stock ( |
21 | 20 | ||||||
Additional paid-in capital | 170,608 | 166,514 | ||||||
|
(28,489 | ) | (28,489 | ) | ||||
Accumulated other comprehensive income | 458 | 412 | ||||||
Accumulated deficit | (72,736 | ) | (62,460 | ) | ||||
Total stockholders’ equity | 69,862 | 75,997 | ||||||
Total liabilities and stockholders’ equity | $ | 105,528 | $ | 97,681 |
Note: Amounts as of
RECONCILIATION OF GAAP TO NON-GAAP RESULTS (Unaudited, in thousands, except per share amounts) |
||||||||||||||||
Three months ended |
Nine months ended |
|||||||||||||||
|
|
|
|
|||||||||||||
Non-GAAP Loss from Operations | ||||||||||||||||
Reported operating loss (GAAP basis) | $ | (324 | ) | $ | (3,780 | ) | $ | (10,447 | ) | $ | (6,436 | ) | ||||
Change in fair value of contingent consideration obligations1 | 52 | (150 | ) | (90 | ) | (350 | ) | |||||||||
Restructuring charges2 | — | — | — | 148 | ||||||||||||
Non-GAAP Operating Loss | $ | (272 | ) | $ | (3,930 | ) | $ | (10,537 | ) | $ | (6,638 | ) | ||||
Non-GAAP Net Loss | ||||||||||||||||
Reported net loss (GAAP basis) | $ | (481 | ) | $ | (3,759 | ) | $ | (10,276 | ) | $ | (6,640 | ) | ||||
Change in fair value of contingent consideration obligations1 | 52 | (150 | ) | (90 | ) | (350 | ) | |||||||||
Restructuring charges2 | — | — | — | 148 | ||||||||||||
Non-GAAP Net Loss | $ | (429 | ) | $ | (3,909 | ) | $ | (10,366 | ) | $ | (6,842 | ) | ||||
Non-GAAP Net Loss Per Diluted Share | ||||||||||||||||
Reported net loss per diluted share (GAAP basis) | $ | (0.02 | ) | $ | (0.17 | ) | $ | (0.50 | ) | $ | (0.29 | ) | ||||
Change in fair value of contingent consideration obligations1 | — | (0.01 | ) | — | (0.02 | ) | ||||||||||
Restructuring charges2 | — | — | — | 0.01 | ||||||||||||
Non-GAAP Net Loss Per Diluted Share | $ | (0.02 | ) | $ | (0.18 | ) | $ | (0.50 | ) | $ | (0.30 | ) | ||||
Weighted average number of diluted shares | 20,869 | 22,004 | 20,704 | 22,621 |
1Results for all periods presented include changes in fair value of contingent consideration obligations associated with the Solar Implant Technology (SIT) acquisition in 2010.
2Results for all periods presented include severance and other employee-related costs related to various restructuring programs.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161101005448/en/
Chief Financial Officer
or
Investor Relations
Source: